Skip to product information
Green pen on a white background
  • Green pen on a white background
  • Semaglutide packaging with PRG branding on a white background
  • Vial of Cagrilintide+Semaglutide research blend on a white background
Cagrilintide 5 mg + Semaglutide 5 mg – Dual Peptide Research Blend

Cagrilintide 5 mg + Semaglutide 5 mg – Dual Peptide Research Blend

€235,00
Shipping calculated at checkout.
Available Research Formats

Cagrilintide + Semaglutide Blend: Research Overview of Dual Peptide Signaling Systems

The Cagrilintide + Semaglutide blend is a dual-peptide formulation studied in the context of metabolic signaling, receptor interactions, and energy regulation pathways.

It combines semaglutide, a glucagon-like peptide-1 receptor (GLP-1R) agonist, with cagrilintide, a long-acting amylin analog. These peptides interact with distinct but complementary receptor systems involved in nutrient sensing, gastrointestinal signaling, and central regulation of energy balance.

In experimental and clinical research settings, these pathways are investigated for their role in appetite signaling, glucose metabolism, and coordinated endocrine responses. The combined formulation is studied to explore how multi-receptor activation influences complex metabolic systems.

Molecular Mechanism of Action at the Cellular and Receptor Level

Semaglutide

Semaglutide is a long-acting GLP-1 receptor agonist with high structural similarity to endogenous GLP-1.

The GLP-1 receptor (GLP-1R) is a class B G-protein-coupled receptor (GPCR) expressed in multiple tissues, including pancreatic cells, gastrointestinal structures, and central nervous system regions.

Upon receptor binding, semaglutide activates Gs protein signaling, leading to increased intracellular cyclic AMP (cAMP) levels and downstream activation of protein kinase A (PKA). These pathways are associated with regulation of insulin signaling, glucagon modulation, and gastrointestinal motility in experimental models.

In central nervous system research, GLP-1R activation is studied for its effects on hypothalamic and brainstem signaling pathways involved in energy intake regulation.

Cagrilintide

Cagrilintide is a long-acting analog of amylin, a peptide co-secreted with insulin.

It binds to calcitonin receptors (CTR) and receptor complexes formed with receptor activity-modifying proteins (RAMPs), collectively referred to as amylin receptors (AMYR).

These receptors are also class B GPCRs and signal primarily through Gs-mediated cAMP pathways.

Cagrilintide is studied for its effects on signaling pathways in the area postrema and other brain regions involved in satiety and gastrointestinal regulation. Its structural modifications support prolonged receptor interaction in experimental systems.

Coordinated Signaling and Pathway Interaction

The combination of semaglutide and cagrilintide is studied for its ability to engage multiple receptor systems simultaneously.

These include:

• GLP-1 receptor-mediated pathways
• amylin receptor (CTR/RAMP) signaling
• central nervous system energy regulation circuits
• gastrointestinal signaling pathways

In research models, these pathways are explored for their combined effects on energy intake regulation, metabolic signaling, and endocrine coordination.

The peptides activate overlapping but distinct neuronal and peripheral systems, allowing investigation of multi-target signaling networks.

Metabolic and Cellular Research Context

In experimental settings, the Cagrilintide + Semaglutide blend is studied in relation to:

• glucose signaling pathways
• hormonal regulation systems
• central and peripheral energy balance signaling
• gastrointestinal motility and feedback mechanisms

These systems are examined to better understand how coordinated receptor activation influences metabolic processes at the cellular and systemic level.

Preclinical and Clinical Research Overview

A substantial body of research exists for the individual components, including both preclinical and clinical investigations.

These studies explore:

• receptor activation profiles
• signaling cascade interactions
• metabolic pathway modulation
• endocrine system responses

Research involving the combined formulation focuses on understanding how dual-peptide systems influence complex biological networks compared to single-pathway approaches.

Summary

The Cagrilintide + Semaglutide blend is a multi-peptide research formulation studied for its interaction with GLP-1 and amylin receptor systems.

Its mechanisms are associated with:

• G-protein-coupled receptor signaling (GPCR)
• cAMP-mediated intracellular pathways
• central and peripheral metabolic regulation
• coordinated endocrine signaling systems

As a research compound, this blend is explored to better understand how multi-receptor peptide systems influence metabolic signaling and biological regulation.

All information presented is based on experimental and clinical research data and is intended for scientific and educational purposes only.
Product Usage

In vitro research or further manufacturing use only. Not for human or animal use.
Peptide Storage

All information provided by PRG is for educational and informational purposes only.

Best Practices for Storing Peptides

To maintain the reliability of laboratory results, correct peptide storage is essential. Proper storage conditions help preserve peptide stability for years while protecting against contamination, oxidation, and breakdown. Although certain peptides are more sensitive than others, following these best practices will greatly extend their shelf life and structural integrity.

  • Short-Term Storage (days to months): Keep peptides cool and protected from light. Temperatures below 4 °C (39 °F) are generally suitable. Lyophilized peptides often remain stable at room temperature for several weeks, but refrigeration is still preferred if use is not immediate.
  • Long-Term Storage (months to years): Store peptides at –80 °C (–112 °F) for maximum stability. Avoid frost-free freezers, as defrost cycles can cause damaging temperature fluctuations.
  • Minimize Freeze–Thaw Cycles: Repeated freezing and thawing accelerates degradation. Instead, divide peptides into aliquots before freezing.

Preventing Oxidation & Moisture Damage

Peptides can be compromised by exposure to moisture and air—especially immediately after removal from a freezer.

  • Let the vial warm to room temperature before opening to prevent condensation.
  • Keep containers sealed as much as possible, and if possible, reseal under a dry, inert gas such as nitrogen or argon.
  • Amino acids like cysteine (C), methionine (M), and tryptophan (W) are particularly sensitive to oxidation.


Storing Peptides in Solution

Peptides in solution have a much shorter lifespan compared to lyophilized form and are prone to bacterial degradation.

  • If storage in solution is unavoidable, use sterile buffers at pH 5–6.
  • Prepare single-use aliquots to avoid repeated freeze–thaw cycles.
  • Most peptide solutions are stable for up to 30 days at 4 °C (39 °F), but sensitive sequences should remain frozen when not in use.


Containers for Peptide Storage

Select containers that are clean, intact, chemically resistant, and appropriately sized for the sample.

  • Glass vials: offer clarity, durability, and chemical resistance.
  • Plastic vials: polystyrene (clear but less resistant) or polypropylene (translucent but chemically resistant).
  • Peptides shipped in plastic vials may be transferred to glass for long-term storage if desired.


Regenesis Peptide Storage Quick Tips

  • Keep peptides in a cold, dry, dark environment
  • Avoid repeated freeze–thaw cycles
  • Minimize exposure to air
  • Protect from light
  • Avoid storing in solution long term
  • Aliquot peptides to match experimental needs
Logo for 'Verified Purity' with a shield design, molecular symbol, and text indicating European laboratory standard.

Analytical Transparency

All PRG research materials are analytically tested for purity and identity under EU laboratory standards. Manufacturer Certificates of Analysis (COA) are available upon request. If independent third-party analytical testing confirms results consistent with our published specifications, PRG may reimburse the verified laboratory testing cost upon review.

You may also like